Eficacia del infliximab en pacientes con síndrome de Behçet portadores de úveo-retinitis grave

• Guillermo Merino ^[1] ; Gonzalo Varas ^[2] ; Gonzalo Díaz ^[3] ; Miguel Gutiérrez ^[2] ; Loreto Massardo ^[2] ; Daniel Pacheco ^[3] ; Francisco Villarroel ^[4] ; Miguel Cuchacovich ^[3]
  1. [1] Clinica Santa Maria

     Clinica Santa Maria

     Santiago, Chile

     
  2. [2] Pontificia Universidad Católica de Chile

     Pontificia Universidad Católica de Chile

     Santiago, Chile

     
  3. [3] Universidad de Chile

     Universidad de Chile

     Santiago, Chile

     
  4. [4] Fundación Oftalmológica Los Andes

  Mostrar afiliaciones +
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 134, Nº. 7, 2006, págs. 875-882
• Idioma: español
• Títulos paralelos:
  • Effectiveness of infliximab in patients with Behçet syndrome and severe uveoretinitis. Report of five cases
• Enlaces
  • Texto completo
• Resumen

  • The efficacy and safety of repeated administration of infliximab was evaluated in five patients (two men, three women) with Behçet syndrome accompanied by severe uveoretinitis. Ocular and extra ocular inflammation was suppressed in all patients during the observation period without any serious adverse reactions. The results in these patients suggests that TNF-á blockade is effective in patients with severe ocular Behçet syndrome